Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop report.

American journal of respiratory cell and molecular biology·2026

Same author

HHIP's dynamic role in epithelial wound healing reveals a potential mechanism of COPD susceptibility.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Joint clinical and molecular subtyping of COPD with variational autoencoders.

Nature communications·2026

Same author

Somatic mutation analysis of mucin genes and pathways in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine·2026

Same author

Mosaic loss of Y chromosome associates with lung function, emphysema, and epigenetic aging.

American journal of respiratory and critical care medicine·2026

Same author

An integrated germline and somatic genomic model for coronary artery disease.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Hypoxia and chronic lung disease.

Rubin M Tuder¹, Jeong H Yun, Anil Bhunia

¹Division of Cardiopulmonary Pathology, Department of Pathology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Research Building, Room 519, Baltimore, MD, 21205, USA. RTuder@jhmi.edu

Journal of Molecular Medicine (Berlin, Germany)

|November 28, 2007

Summary

This summary is machine-generated.

Hypoxia impairs lung oxygen uptake through various mechanisms, affecting lung development and diseases like infant lung issues, pulmonary hypertension, and COPD. Understanding these molecular pathways is crucial for improving oxygenation.

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Published on: November 2, 2015

Related Experiment Videos

Last Updated: Jul 9, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Published on: November 2, 2015

Area of Science:

Pulmonary Medicine
Molecular Biology
Physiology

Background:

The lungs are vital for oxygen uptake but are susceptible to hypoxia, a condition of low oxygen.
Various lung pathologies, including airway obstruction and inflammation, impede oxygen diffusion, increasing the alveolar-arterial pO2 gradient and reducing tissue oxygenation.

Purpose of the Study:

To review the intricate relationship between hypoxia and lung development.
To explore the molecular mechanisms driving hypoxia-induced physiological and pathophysiological processes in the lung.
To specifically examine hypoxia's role in infant lung conditions, pulmonary hypertension, and chronic obstructive pulmonary disease (COPD).

Main Methods:

Literature review focusing on hypoxia and lung function.
Analysis of molecular pathways involved in hypoxia signaling.
Examination of clinical and developmental aspects of lung diseases associated with hypoxia.

Main Results:

Hypoxia significantly compromises oxygenation by creating barriers to gas exchange.
Molecular signaling in response to hypoxia plays a critical role in both normal lung development and disease pathogenesis.
Specific focus areas reveal distinct hypoxia-driven alterations in the infant lung, pulmonary vasculature, and airways.

Conclusions:

Hypoxia presents a multifaceted challenge to lung function, impacting development and exacerbating disease.
Molecular mechanisms underlying hypoxia are key targets for therapeutic interventions in various lung conditions.
Further research into hypoxia signaling is essential for advancing treatments for infant lung diseases, pulmonary hypertension, and COPD.